Tuesday, July 22, 2014 2:29:11 PM
Investors aren't in urge to make a move on this.
Shot in the dark?
Imo.
Shot in the dark?
Imo.
Recent BIXT News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 10:23:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 01:05:14 PM
- BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT • GlobeNewswire Inc. • 03/20/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 08:00:24 PM
- Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M • GlobeNewswire Inc. • 03/04/2026 08:40:00 PM
- Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19 • ACCESS Newswire • 03/02/2026 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 02:22:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 11:20:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 11:04:17 AM
- Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran • GlobeNewswire Inc. • 02/11/2026 11:00:00 AM
- Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics • GlobeNewswire Inc. • 02/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 10:01:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 11:15:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:15:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:02:52 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/18/2025 06:12:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:00:57 PM
- Bioxytran Announces Initiation of Coverage of its Stock by Independent Research • GlobeNewswire Inc. • 11/13/2025 06:50:00 PM
- Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug • GlobeNewswire Inc. • 10/29/2025 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2025 11:01:03 AM
